Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous adipose-derived mesenchymal stem cells (1 trial)
fab117-hc (1 trial)
allogeneic adipose derived mesenchymal stem cell (1 trial)
Spinal Cord Injuries (Phase 2)
Stroke (Phase 1)
Wounds and Injuries (Phase 2)
Trials (3 total)
Trial APIs (3 total)